Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Steven Niedelman steps down

This article was originally published in The Gray Sheet

Executive Summary

Deputy Associate Commissioner for Regulatory Operations announces he will retire from FDA at the end of June to become Executive VP at Quintiles Consulting. Niedelman began his career at FDA in 1972 as a consumer safety officer. Before taking the ORA post in 2002, he served as acting director of the Office of Enforcement, where he started as deputy director in July 2001. Early this year, Niedelman was named to a team charged with prioritizing device center initiatives and overseeing the implementation of CDRH's postmarket transformation (1"The Gray Sheet" Jan. 23, 2006, p. 5)...
Advertisement

Related Content

People In Brief
FDA Unveils Medical Device “Postmarket Transformation”
FDA Unveils Medical Device “Postmarket Transformation”
Advertisement
UsernamePublicRestriction

Register

MT023685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel